Aptevo Therapeutics Inc. (APVO)

Aptevo Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	1	3	12	39	152	30
Market Cap Growth	-83.02%	-73.01%	-69.36%	-74.63%	412.61%	2.85%
Enterprise Value	-4	-8	-1	9	137	40
PE Ratio	-	-0.18	1.47	-1.35	-8.56	-0.73
PS Ratio	-	-	3.79	3.14	35.26	-
PB Ratio	0.20	0.26	0.66	31.70	9.15	2.50
P/FCF Ratio	-0.11	-0.27	-0.56	-1.72	-5.17	-0.70
P/OCF Ratio	-0.11	-0.27	-0.56	-1.78	-5.18	-0.70
EV/Sales Ratio	-	-	-0.41	0.73	31.75	-
EV/EBITDA Ratio	0.10	0.49	-0.14	-0.33	-8.37	-1.06
EV/EBIT Ratio	0.09	0.48	-0.16	-0.31	-7.71	-1.00
EV/FCF Ratio	0.11	0.71	0.06	-0.40	-4.65	-0.95
Debt / Equity Ratio	0.85	0.44	0.53	13.75	1.65	1.96
Debt / EBITDA Ratio	-0.20	-0.32	1.07	-0.61	-1.68	-0.61
Debt / FCF Ratio	-0.23	-0.46	-0.45	-0.75	-0.93	-0.55
Quick Ratio	1.63	2.34	2.89	1.44	3.09	0.33
Current Ratio	1.92	2.64	3.15	1.51	3.25	0.78
Asset Turnover	0	0	0.08	0.19	0.13	0
Return on Equity (ROE)	-219.20%	-104.80%	63.10%	-346.10%	-166.70%	-166.90%
Return on Assets (ROA)	-109.70%	-60.10%	21.40%	-43.60%	-52.70%	-62.00%
Return on Capital (ROIC)	-248.35%	-163.91%	-104.12%	-119.35%	-65.49%	-116.93%
Earnings Yield	-2221.89%	-546.03%	67.95%	-73.82%	-11.68%	-136.49%
FCF Yield	-1887.03%	-367.87%	-178.20%	-58.09%	-19.36%	-143.53%
Buyback Yield / Dilution	-330.29%	-139.76%	-8.85%	-38.25%	-16.25%	-81.50%
Total Shareholder Return	-330.29%	-139.76%	-8.85%	-38.25%	-16.25%	-81.50%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).